Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2017

01-07-2017 | Erratum

Erratum to: Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: a useful contributor to cutaneous disease control

Authors: M. Bourke, D. Soden, A. J. P. Clover

Published in: Breast Cancer Research and Treatment | Issue 1/2017

Login to get access

Excerpt

In the original publication of the article, the last name of the cited author, Luca G Campana was incorrectly and inconsistently spelled throughout the article as Campagna. The correct last name of the cited author is Campana. …
Metadata
Title
Erratum to: Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: a useful contributor to cutaneous disease control
Authors
M. Bourke
D. Soden
A. J. P. Clover
Publication date
01-07-2017
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2017
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4307-4

Other articles of this Issue 1/2017

Breast Cancer Research and Treatment 1/2017 Go to the issue

Epidemiology

Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival

Letter to the Editor

Racial disparity in vitamin D status may explain racial disparity in survival from estrogen and progesterone receptor-positive breast cancer

Editorial

The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis

Epidemiology

Breast cancer in Asian Americans in California, 1988–2013: increasing incidence trends and recent data on breast cancer subtypes

Review

Ablative Therapies in Metastatic Breast Cancer: A Systematic Review

Epidemiology

Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits